{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T13:56:25Z","timestamp":1772459785447,"version":"3.50.1"},"reference-count":72,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>HLA-DRB1 is the major genetic risk factor for visceral leishmaniasis (VL). We used SNP2HLA to impute HLA-DRB1 alleles and SNPTEST to carry out association analyses in 889 human cases and 977 controls from India. NetMHCIIpan 2.1 was used to map epitopes and binding affinities across 49 Leishmania vaccine candidates, as well as across peptide epitopes captured from dendritic cells treated with crude Leishmania Ag and identified using mass spectrometry and alignment to amino acid sequences of a reference Leishmania genome. Cytokines were measured in peptide-stimulated whole blood from 26 cured VL cases and eight endemic healthy controls. HLA-DRB1*1501 and DRB1*1404\/DRB1*1301 were the most significant protective and risk alleles, respectively, with specific residues at aa positions 11 and 13 unique to protective alleles. We observed greater peptide promiscuity in sequence motifs for 9-mer core epitopes predicted to bind to risk (*1404\/*1301) compared with protective (*1501) DRB1 alleles. There was a higher frequency of basic amino acids in DRB1*1404\/*1301-specific epitopes compared with hydrophobic and polar amino acids in DRB1*1501-specific epitopes at anchor residues pocket 4 and pocket 6, which interact with residues at DRB1 positions 11 and 13. Cured VL patients made variable, but robust, IFN-\u03b3, TNF, and IL-10 responses to 20-mer peptides based on captured epitopes, with peptides based on DRB1*1501-captured epitopes resulting in a higher proportion (odds ratio 2.23, 95% confidence interval 1.17\u20134.25, p = 0.017) of patients with IFN-\u03b3\/IL-10 ratios &amp;gt; 2-fold compared with peptides based on DRB1*1301-captured epitopes. Our data provide insight into the molecular mechanisms underpinning the association of HLA-DRB1 alleles with risk versus protection in VL in humans.<\/jats:p>","DOI":"10.4049\/jimmunol.1701764","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T16:50:10Z","timestamp":1520268610000},"page":"2727-2737","source":"Crossref","is-referenced-by-count":22,"title":["Epitope-Binding Characteristics for Risk versus Protective DRB1 Alleles for Visceral Leishmaniasis"],"prefix":"10.1093","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0324-7821","authenticated-orcid":false,"given":"Toolika","family":"Singh","sequence":"first","affiliation":[{"name":"Institute of Medical Sciences, Banaras Hindu University , Varanasi OS 221 005,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Fakiola","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Cambridge , Cambridge CB2 1QP,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce","family":"Oommen","sequence":"additional","affiliation":[{"name":"Telethon Kids Institute, The University of Western Australia , Subiaco, Western Australia 6008,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhil Pratap","family":"Singh","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Banaras Hindu University , Varanasi OS 221 005,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek K","family":"Singh","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Banaras Hindu University , Varanasi OS 221 005,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Smith","sequence":"additional","affiliation":[{"name":"Lonza Biologics PLC , Great Abington, Cambridge CB21 6GS,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya","family":"Chakravarty","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Banaras Hindu University , Varanasi OS 221 005,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9988-582X","authenticated-orcid":false,"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[{"name":"Institute of Medical Sciences, Banaras Hindu University , Varanasi OS 221 005,","place":["India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-7277","authenticated-orcid":false,"given":"Jenefer M","family":"Blackwell","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Cambridge , Cambridge CB2 1QP,","place":["United Kingdom"]},{"name":"Telethon Kids Institute, The University of Western Australia , Subiaco, Western Australia 6008,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,4,15]]},"reference":[{"key":"2025030610143708000_r1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4269\/ajtmh.1995.52.364","article-title":"Familial aggregation of Leishmania chagasi infection in northeastern Brazil","volume":"52","author":"Cabello","year":"1995","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2025030610143708000_r2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/gepi.8","article-title":"Genetic epidemiology of visceral leishmaniasis in northeastern Brazil","volume":"20","author":"Peacock","year":"2001","journal-title":"Genet. Epidemiol."},{"key":"2025030610143708000_r3","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1017\/S0031182000076678","article-title":"Genetic susceptibility to leishmanial infections: studies in mice and man","volume":"112","author":"Blackwell","year":"1996","journal-title":"Parasitology"},{"key":"2025030610143708000_r4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/283072a0","article-title":"Influence of H-2 complex on acquired resistance to Leishmania donovani infection in mice","volume":"283","author":"Blackwell","year":"1980","journal-title":"Nature"},{"key":"2025030610143708000_r5","doi-asserted-by":"crossref","first-page":"A58","DOI":"10.1016\/S0167-5699(05)80017-9","article-title":"Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function","volume":"12","author":"Locksley","year":"1991","journal-title":"Immunol. Today"},{"key":"2025030610143708000_r6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4269\/ajtmh.1997.56.522","article-title":"Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis","volume":"56","author":"Sundar","year":"1997","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2025030610143708000_r7","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI116372","article-title":"In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma","volume":"91","author":"Karp","year":"1993","journal-title":"J. Clin. Invest."},{"key":"2025030610143708000_r8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/517817","article-title":"Splenic cytokine responses in Indian kala-azar before and after treatment","volume":"177","author":"Kenney","year":"1998","journal-title":"J. Infect. Dis."},{"key":"2025030610143708000_r9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1084\/jem.20061141","article-title":"Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis","volume":"204","author":"Nyl\u00e9n","year":"2007","journal-title":"J. Exp. Med."},{"key":"2025030610143708000_r10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Nyl\u00e9n","year":"2007","journal-title":"Trends Immunol."},{"key":"2025030610143708000_r11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/infdis\/165.3.535","article-title":"Immunologic markers of clinical evolution in children recently infected with Leishmania donovani chagasi","volume":"165","author":"Carvalho","year":"1992","journal-title":"J. Infect. Dis."},{"key":"2025030610143708000_r12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/sj.gene.6364357","article-title":"Genome-wide scan for visceral leishmaniasis susceptibility genes in Brazil","volume":"8","author":"Jamieson","year":"2007","journal-title":"Genes Immun."},{"key":"2025030610143708000_r13","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/521682","article-title":"Genetic predisposition to self-curing infection with the protozoan Leishmania chagasi: a genomewide scan","volume":"196","author":"Jeronimo","year":"2007","journal-title":"J. Infect. Dis."},{"key":"2025030610143708000_r14","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1371\/journal.pgen.0030071","article-title":"Y chromosome lineage- and village-specific genes on chromosomes 1p22 and 6q27 control visceral leishmaniasis in Sudan","volume":"3","author":"Miller","year":"2007","journal-title":"PLoS Genet."},{"key":"2025030610143708000_r15","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1086\/379084","article-title":"A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar","volume":"73","author":"Bucheton","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"2025030610143708000_r16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1128\/CMR.00048-08","article-title":"HLA and infectious diseases","volume":"22","author":"Blackwell","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"2025030610143708000_r17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/ng.2518","article-title":"Common variants in the HLA-DRB1\u2013HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis","volume":"45","author":"Fakiola","year":"2013","journal-title":"Nat. Genet."},{"key":"2025030610143708000_r18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coi.2005.11.002","article-title":"The wide diversity and complexity of peptides bound to class II MHC molecules","volume":"18","author":"Suri","year":"2006","journal-title":"Curr. Opin. Immunol."},{"key":"2025030610143708000_r19","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/ni1206-1277","article-title":"From antigen processing to peptide-MHC binding","volume":"7","author":"Unanue","year":"2006","journal-title":"Nat. Immunol."},{"key":"2025030610143708000_r20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-7580-6-9","article-title":"NetMHCIIpan-2.0 - Improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure","volume":"6","author":"Nielsen","year":"2010","journal-title":"Immunome Res."},{"key":"2025030610143708000_r21","doi-asserted-by":"crossref","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","article-title":"Imputing amino acid polymorphisms in human leukocyte antigens","volume":"8","author":"Jia","year":"2013","journal-title":"PLoS One"},{"key":"2025030610143708000_r22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1375.001","article-title":"The Type 1 Diabetes Genetics Consortium","volume":"1079","author":"Rich","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025030610143708000_r23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nature"},{"key":"2025030610143708000_r24","doi-asserted-by":"crossref","first-page":"705821","DOI":"10.1155\/2010\/705821","article-title":"MHC class II binding prediction-a little help from a friend","volume":"2010","author":"Dimitrov","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"2025030610143708000_r25","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/1471-2105-11-568","article-title":"Peptide binding predictions for HLA DR, DP and DQ molecules","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"2025030610143708000_r26","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/1471-2105-10-296","article-title":"NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction","volume":"10","author":"Nielsen","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"2025030610143708000_r27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jim.2013.08.014","article-title":"BlockLogo: visualization of peptide and sequence motif conservation","volume":"400\u2013401","author":"Olsen","year":"2013","journal-title":"J. Immunol. Methods"},{"key":"2025030610143708000_r28","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1093\/nar\/18.20.6097","article-title":"Sequence logos: a new way to display consensus sequences","volume":"18","author":"Schneider","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"2025030610143708000_r29","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res."},{"key":"2025030610143708000_r30","doi-asserted-by":"crossref","first-page":"e86322","DOI":"10.1371\/journal.pone.0086322","article-title":"Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro. [Published erratum appears in 2014 PLoS One 9: e93339.]","volume":"9","author":"Rombach-Riegraf","year":"2014","journal-title":"PLoS One"},{"key":"2025030610143708000_r31","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.175.4.2517","article-title":"IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection","volume":"175","author":"Stober","year":"2005","journal-title":"J. Immunol."},{"key":"2025030610143708000_r32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.139.1.221","article-title":"Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes","volume":"139","author":"Scott","year":"1987","journal-title":"J. Immunol."},{"key":"2025030610143708000_r33","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00251-007-0224-8","article-title":"The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function","volume":"59","author":"Bondinas","year":"2007","journal-title":"Immunogenetics"},{"key":"2025030610143708000_r34","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"St\u00e4ger","year":"2000","journal-title":"J. Immunol."},{"key":"2025030610143708000_r35","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"2025030610143708000_r36","doi-asserted-by":"crossref","first-page":"e1874","DOI":"10.1371\/journal.pntd.0001874","article-title":"Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis","volume":"6","author":"Singh","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2025030610143708000_r37","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.imbio.2014.01.005","article-title":"Whole blood assay and visceral leishmaniasis: Challenges and promises","volume":"219","author":"Singh","year":"2014","journal-title":"Immunobiology"},{"key":"2025030610143708000_r38","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/cid\/ciu102","article-title":"Asymptomatic Leishmania infection: a new challenge for Leishmania control","volume":"58","author":"Singh","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"2025030610143708000_r39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-5699(97)01237-1","article-title":"How the MHC selects Th1\/Th2 immunity","volume":"19","author":"Murray","year":"1998","journal-title":"Immunol. Today"},{"key":"2025030610143708000_r40","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1002\/eji.1830251123","article-title":"The presence of the HLA class II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen","volume":"25","author":"Stephens","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"2025030610143708000_r41","doi-asserted-by":"crossref","first-page":"9456","DOI":"10.1073\/pnas.91.20.9456","article-title":"Definition of a human suppressor T-cell epitope","volume":"91","author":"Mutis","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030610143708000_r42","doi-asserted-by":"crossref","first-page":"9510","DOI":"10.1073\/pnas.92.21.9510","article-title":"Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4\/5 or interferon gamma by T cells","volume":"92","author":"Kumar","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030610143708000_r43","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.immuni.2007.11.007","article-title":"Structures of an MHC class I molecule from B21 chickens illustrate promiscuous peptide binding","volume":"27","author":"Koch","year":"2007","journal-title":"Immunity"},{"key":"2025030610143708000_r44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JVI.05577-11","article-title":"HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome","volume":"86","author":"Ranasinghe","year":"2012","journal-title":"J. Virol."},{"key":"2025030610143708000_r45","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.4049\/jimmunol.175.6.3603","article-title":"Broad repertoire of the CD4+ Th cell response in spontaneously controlled hepatitis C virus infection includes dominant and highly promiscuous epitopes","volume":"175","author":"Schulze zur Wiesch","year":"2005","journal-title":"J. Immunol."},{"key":"2025030610143708000_r46","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.4049\/jimmunol.1302101","article-title":"HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity","volume":"191","author":"Paul","year":"2013","journal-title":"J. Immunol."},{"key":"2025030610143708000_r47","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.3229","article-title":"Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control","volume":"19","author":"Ranasinghe","year":"2013","journal-title":"Nat. Med."},{"key":"2025030610143708000_r48","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/infdis\/163.4.853","article-title":"Tumor necrosis factor (cachectin) in human visceral leishmaniasis","volume":"163","author":"Barral-Netto","year":"1991","journal-title":"J. Infect. Dis."},{"key":"2025030610143708000_r49","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1128\/IAI.73.8.5286-5289.2005","article-title":"Prime-boost vaccination using the LACK antigen protects against murine visceral leishmaniasis","volume":"73","author":"Dondji","year":"2005","journal-title":"Infect. Immun."},{"key":"2025030610143708000_r50","first-page":"2975","article-title":"Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene","volume":"14","author":"Charest","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"2025030610143708000_r51","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.1073\/pnas.96.20.11015","article-title":"Cysteine protease inhibitors as chemotherapy: lessons from a parasite target","volume":"96","author":"Selzer","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025030610143708000_r52","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.vaccine.2005.11.011","article-title":"Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"key":"2025030610143708000_r53","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.vaccine.2008.08.065","article-title":"Cysteine proteinase type III is protective against Leishmania infantum infection in BALB\/c mice and highly antigenic in visceral leishmaniasis individuals","volume":"26","author":"Khoshgoo","year":"2008","journal-title":"Vaccine"},{"key":"2025030610143708000_r54","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/iai.63.11.4261-4267.1995","article-title":"Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response","volume":"63","author":"Handman","year":"1995","journal-title":"Infect. Immun."},{"key":"2025030610143708000_r55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7555\/JBR.30.20150125","article-title":"Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB\/c mice","volume":"30","author":"Kaur","year":"2016","journal-title":"J. Biomed. Res."},{"key":"2025030610143708000_r56","doi-asserted-by":"crossref","first-page":"202ra121","DOI":"10.1126\/scitranslmed.3006406","article-title":"Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis","volume":"5","author":"Guha","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"2025030610143708000_r57","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2005.12.012","article-title":"From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection","volume":"24","author":"Stober","year":"2006","journal-title":"Vaccine"},{"key":"2025030610143708000_r58","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.vaccine.2008.12.053","article-title":"KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major","volume":"27","author":"Bhaumik","year":"2009","journal-title":"Vaccine"},{"key":"2025030610143708000_r59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1756-3305-7-3","article-title":"Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis","volume":"7","author":"Ramirez","year":"2014","journal-title":"Parasit. Vectors"},{"key":"2025030610143708000_r60","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a recombinant polyprotein vaccine that protects against visceral leishmaniasis by elicitation of CD4+ T cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"key":"2025030610143708000_r61","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0264-410X(00)00398-4","article-title":"Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters","volume":"19","author":"Fragaki","year":"2001","journal-title":"Vaccine"},{"key":"2025030610143708000_r62","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"key":"2025030610143708000_r63","doi-asserted-by":"crossref","first-page":"e12345","DOI":"10.1111\/pim.12345","article-title":"Immune response to recombinant Leishmania infantum lipophosphoglycan 3 plus CpG oligodeoxynucleotides in BALB\/c mice","volume":"39","author":"Pirdel","year":"2017","journal-title":"Parasite Immunol."},{"key":"2025030610143708000_r64","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect. Immun."},{"key":"2025030610143708000_r65","doi-asserted-by":"crossref","first-page":"e0003751","DOI":"10.1371\/journal.pntd.0003751","article-title":"Coadministration of the three antigenic Leishmania infantum poly (A) binding proteins as a DNA vaccine induces protection against Leishmania major infection in BALB\/c mice","volume":"9","author":"Soto","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2025030610143708000_r66","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.exppara.2011.07.001","article-title":"Immunogenicity of Leishmania donovani iron superoxide dismutase B1 and peroxidoxin 4 in BALB\/c mice: the contribution of Toll-like receptor agonists as adjuvant","volume":"129","author":"Daifalla","year":"2011","journal-title":"Exp. Parasitol."},{"key":"2025030610143708000_r67","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1128\/IAI.71.11.6562-6572.2003","article-title":"The Leishmania infantum acidic ribosomal protein P0 administered as a DNA vaccine confers protective immunity to Leishmania major infection in BALB\/c mice","volume":"71","author":"Iborra","year":"2003","journal-title":"Infect. Immun."},{"key":"2025030610143708000_r68","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.vaccine.2004.07.044","article-title":"Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana","volume":"23","author":"Saravia","year":"2005","journal-title":"Vaccine"},{"key":"2025030610143708000_r69","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.vaccine.2012.12.071","article-title":"Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis","volume":"31","author":"Ram\u00edrez","year":"2013","journal-title":"Vaccine"},{"key":"2025030610143708000_r70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/pim.12206","article-title":"Analysis of iron superoxide dismutase-encoding DNA vaccine on the evolution of the Leishmania amazonensis experimental infection","volume":"37","author":"Campos","year":"2015","journal-title":"Parasite Immunol."},{"key":"2025030610143708000_r71","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4269\/ajtmh.2010.09-0341","article-title":"Evaluation of ex vivo human immune response against candidate antigens for a visceral leishmaniasis vaccine","volume":"82","author":"Kumar","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2025030610143708000_r72","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1016\/j.vaccine.2014.04.088","article-title":"Leishmania genome analysis and high-throughput immunological screening identifies tuzin as a novel vaccine candidate against visceral leishmaniasis","volume":"32","author":"Lakshmi","year":"2014","journal-title":"Vaccine"}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/200\/8\/2727\/62230542\/ji1701764.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/200\/8\/2727\/62230542\/ji1701764.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T10:36:22Z","timestamp":1741257382000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/200\/8\/2727\/7966327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,4,15]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1701764","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,4]]},"published":{"date-parts":[[2018,4]]}}}